Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Wander, Seth
Item TypeName
Concept Cyclin-Dependent Kinase 2
Concept Cyclin-Dependent Kinase 6
Concept Cyclin-Dependent Kinase Inhibitor Proteins
Concept Cyclin-Dependent Kinase Inhibitor p27
Concept Cyclin-Dependent Kinase 4
Academic Article PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy.
Academic Article p27 as Jekyll and Hyde: regulation of cell cycle and cell motility.
Academic Article Combined Src and ER blockade impairs human breast cancer proliferation in vitro and in vivo.
Academic Article RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility.
Academic Article p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies.
Academic Article Blocking the Cycle: Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic, Hormone Receptor-Positive Breast Cancer.
Academic Article Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor-directed therapies.
Academic Article p27 transcriptionally coregulates cJun to drive programs of tumor progression.
Academic Article MicroRNA-Mediated Suppression of the TGF-ß Pathway Confers Transmissible and Reversible CDK4/6 Inhibitor Resistance.
Academic Article CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions.
Academic Article Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future.
Academic Article The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor-Positive Metastatic Breast Cancer.
Search Criteria
  • Cyclin Dependent Kinase 3
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.